cerebrospin
fluid
csf
plasma
level
oral
administr
concentr
consider
lower
im
administr
concentr
ofdha
high
day
almost
nil
day
indic
fast
inactiv
dog
two
hour
th
oral
administr
neither
dha
detect
csf
may
explain
absenc
neurotox
dog
oral
administr
artemeth
antimalari
drug
deriv
artemisinin
qinghaosu
extract
herb
artemisia
annua
l
sweet
wormwood
antiparasit
effect
schizontocid
explain
rapid
uptak
parasit
erythrocyt
interact
compon
ofhemoglobin
degrad
result
format
free
radic
shown
exhibit
high
clinic
cure
rate
previou
anim
safeti
studi
qinghaosu
deriv
reveal
dosedepend
neurotox
movement
disturb
neuropath
chang
hindbrain
intramuscularli
treat
dog
rat
monkey
effect
seen
man
object
present
studi
compar
effect
high
level
administ
dog
po
versu
im
pilot
studi
mgkgday
given
im
group
male
beagl
dog
day
respect
clinic
sign
neurotox
note
individu
dog
test
day
one
dog
sacrif
preterm
hematolog
find
indic
hypochrom
microcyt
anemia
microscop
examin
demonstr
neuropath
chang
day
day
anim
neuron
secondari
axon
damag
promin
cerebellar
roof
pontin
vestibular
nuclei
rapheparalemnisc
region
affect
neuron
show
loss
ofnissl
substanc
cytoplasm
eosinophilia
shrinkag
nucleu
advanc
stage
scaveng
microglia
subsequ
experi
administ
group
male
femal
dog
respect
daili
dose
mgkg
im
mgkg
po
neurolog
sign
seen
high
im
dose
anim
inconspicu
consist
reduc
activ
convuls
seen
singl
dog
shortli
death
neuron
damag
occur
anim
mgkg
follow
im
treatment
mgkg
minim
effect
occur
dog
indic
level
close
toler
exposur
compar
lesion
observ
oral
administr
im
po
exposur
high
dose
level
associ
prolong
mean
qt
interv
ecg
suggest
slow
repolar
myocardium
individu
data
indic
femal
mgkg
im
prolong
level
consid
threshold
concern
intramuscular
administr
pharmacokinet
indic
peak
plasma
level
hour
postdos
slow
elimin
tendenc
accumul
repeat
administr
low
level
major
metabolit
dihydroartemisinin
dha
found
level
deriv
artemisinin
qinghaosu
extract
herb
artemisia
annua
l
sweet
wormwood
qinghao
promis
new
antimalari
current
avail
treatment
malaria
caus
multipl
resist
plasmodium
falciparum
high
clinic
cure
rate
widespread
use
especi
southeast
asia
resist
antimalari
becom
common
kamchongwongpaisan
et
al
karbwang
et
al
chemic
artemisinin
sesquiterpen
lacton
peroxid
structur
antiparasit
effect
explain
rapid
uptak
parasit
erythrocyt
interact
compon
hemoglobin
degrad
result
format
free
radic
antimalari
activ
increas
reduc
lacton
oxygen
yield
dihydroartemisinin
dha
deriv
ether
ester
analogu
deriv
includ
artemeth
arteeth
ae
appear
similar
physic
chemic
antiparasit
properti
agent
shown
effect
blood
stage
malaria
parasit
schizont
produc
littl
clinic
toxic
chang
electrocardiogram
ecg
ae
select
us
armi
world
health
organ
develop
remedi
sever
malaria
brewer
et
al
although
seriou
advers
effect
report
clinic
trial
human
kamchonwongpaisan
et
al
experi
ae
anim
demonstr
neurotox
follow
intramuscular
administr
dog
rat
monkey
brewer
et
al
brewer
et
al
petra
et
al
genoves
et
al
anim
studi
compound
administ
parenter
prolong
time
period
contrast
clinic
trial
indic
rapid
clear
parasit
therebi
limit
treatment
day
differ
treatment
durat
intramuscular
anim
studi
clinic
situat
greatli
imped
risk
assess
base
data
use
short
administr
period
compar
clinic
patholog
effect
pharmacokinet
oral
intramuscular
rout
administr
consid
better
basi
extrapol
man
estim
safeti
margin
neurotox
effect
use
intend
clinic
trial
therefor
present
experi
treatment
limit
day
closer
maximum
day
treatment
intend
human
long
enough
neural
lesion
develop
brewer
et
al
experi
dog
describ
report
demonstr
characterist
neural
lesion
highlevel
intramuscular
treatment
total
absenc
follow
oral
administr
two
separ
experi
carri
experi
subserv
replic
publish
data
order
verifi
sensit
anim
method
use
character
neurotox
effect
system
toxic
produc
intramuscular
im
administr
experi
ii
administ
oral
intramuscular
rout
variou
dose
level
test
neurotox
potenti
condit
similar
intend
clinic
use
studi
healthi
pedigre
beagl
dog
initi
age
week
use
anim
underw
antiparasit
therapi
vaccin
rabi
distemp
leptospirosi
infecti
canin
hepat
kennel
cough
parvoviru
coronaviru
hous
pair
solidbottom
kennel
avail
indoor
outdoor
run
total
area
light
provid
least
hour
daili
room
temperatur
maintain
certifi
pellet
standard
diet
nafag
eberl
nafag
ag
gossau
switzerland
given
g
per
anim
daili
tap
water
freeli
avail
inject
solut
peanut
oil
mgml
kunm
pharmaceut
corp
china
use
intramuscular
administr
control
anim
receiv
steril
peanut
oil
oral
administr
artemeth
administ
gelatin
capsul
activ
substanc
white
crystallin
powder
novarti
pharma
ag
switzerland
control
anim
receiv
empti
gelatin
capsul
exp
toxic
experi
dose
mgkg
im
select
therapeut
dose
expect
produc
toxic
prolong
administr
group
one
control
treat
male
dog
dose
day
dog
total
test
control
articl
administ
daili
equal
volum
mlkg
gluteal
infraspin
muscl
altern
hind
leg
foreleg
clinic
investig
includ
observ
mortal
gener
clinic
sign
detail
neurolog
examin
bodi
weight
food
consumpt
ophthalmolog
electrocardiographi
clinic
laboratori
investig
blood
biochemistri
hematolog
urinalysi
pharmacokinet
ecg
measur
cardiovet
schillerreom
ag
dietikon
switzerland
sixchannel
electrocardiograph
use
dog
held
right
later
recumb
forelimb
hindlimb
perpendicular
bodi
limb
lead
einthoven
ii
ill
augment
unipolar
lead
goldberg
vr
vl
vf
thorac
lead
wilson
vi
use
heart
rate
hr
pwave
p
pqinterv
pq
qrscomplex
qr
qtinterv
qt
measur
period
second
averag
integr
measur
program
addit
electrocardiograph
trace
visual
compar
pretest
pattern
dog
pqand
qt
interv
vari
heart
rate
adjust
rrinterv
msec
correspond
heart
rate
use
follow
equat
pq
rr
qt
rr
pharmacokinet
ml
blood
drawn
antebrachi
cephal
jugular
vein
heparin
tube
immedi
centrifug
rpm
minut
plasma
immedi
transfer
ml
polypropylen
tube
store
dri
ice
sampl
cerebrospin
fluid
drawn
cisterna
magna
immedi
transfer
polypropylen
tube
store
dri
ice
sampl
kept
analysi
use
hplc
method
sandrenan
et
al
patholog
examin
surviv
anim
necropsi
hour
last
administr
one
moribund
dog
necropsi
prematur
studi
day
deep
anesthesia
induc
mlkg
iv
addit
iu
heparin
follow
wholebodi
perfus
neutral
phosphatebuff
formalin
total
differ
organ
tissu
includ
brain
optic
nerv
peripher
nerv
sciatic
plantar
skelet
muscl
quadricep
femori
inject
site
spinal
cord
taken
anim
postfix
formalin
specimen
embed
paraplast
section
nomin
micron
stain
hematoxylin
eosin
examin
lightmicroscop
brain
section
multipl
transvers
level
obtain
brain
region
report
suscept
brewer
et
al
improv
definit
brain
lesion
special
stain
appli
select
duplic
section
cresyl
violet
nissl
stain
bind
lectin
rcal
marker
microglia
cell
bodian
silver
stain
neurofila
axon
combin
luxol
fast
blue
counterstain
myelin
sheath
addit
sampl
cervic
cl
thorac
tl
spinal
cord
postfix
glutaraldehyd
impregn
dalton
solut
embed
epoxi
resin
section
micron
stain
toluidin
blue
prepar
examin
light
microscop
experi
total
dog
use
administ
daili
consecut
day
group
male
femal
dog
either
intramuscular
oral
rout
intramuscular
dosag
mglkg
inject
volum
mllkg
control
group
receiv
mllkg
steril
peanut
oil
inject
site
gluteal
infraspin
muscl
oral
administr
perform
hour
feed
daili
dosag
mglkg
clinic
investig
includ
gener
clinic
sign
detail
neurolog
examin
bodi
weight
food
consumpt
electrocardiographi
ecg
pharmacokinet
describ
experi
patholog
examin
anim
deepli
anesthet
perfus
formalin
experi
follow
perfus
brain
remov
postfix
one
highdos
im
treat
femal
die
spontan
day
brain
anim
remov
fix
immers
formalin
brain
divid
two
part
longitudinalvert
cut
mm
left
midlin
right
larger
part
postfix
formalin
use
paraffin
process
left
smaller
part
cut
multipl
transvers
slice
mm
thick
postfix
glutaraldehyd
option
embed
epoxi
resin
perform
select
specimen
tissu
embed
paraffin
section
nomin
micron
stain
hematoxylin
eosin
duplic
brain
section
im
treat
anim
highdos
control
anim
treat
oral
stain
cresyl
violet
brain
area
identifi
experi
highli
suscept
examin
establish
doseeffect
relationship
cerebellar
roof
nuclei
pontin
nuclei
vestibular
nuclei
paralemnisc
raph
region
bodi
weight
food
consumpt
data
compar
control
group
wilcoxon
twosampl
test
test
increas
decreas
trend
control
respect
dose
group
jonckheer
test
order
altern
electrocardiograph
data
analyz
parametr
pcsa
procedur
treat
group
compar
control
group
repeat
test
base
pool
varianc
estim
group
mean
test
linear
trend
control
highest
dose
group
group
number
clinic
investig
pharmacokinet
test
day
singl
anim
show
tremor
restless
sign
improv
day
dog
appear
perfectli
normal
next
morn
test
day
dog
show
sway
gait
aggress
next
morn
despit
discontinu
treatment
found
recumb
dyspnea
poor
gener
condit
thu
sacrif
preterm
day
anim
may
convuls
overnight
shortli
plan
sacrific
test
day
anoth
anim
show
tonicclon
convuls
end
opistothonu
toxicolog
relev
clinic
sign
chang
behavior
observ
time
experi
although
food
consumpt
reduc
week
bodi
weight
develop
affect
treatment
hematolog
find
day
indic
hypochrom
microcyt
anemia
relev
chang
observ
opthalmoscop
neurolog
examin
anim
electrocardiograph
examin
indic
trend
toward
prolong
qt
interv
effect
minim
observ
individu
anim
consid
equivoc
relev
pharmacokinet
indic
plasma
profil
compar
produc
human
intramuscular
administr
zhou
et
al
patholog
postmortem
examin
day
treatment
reveal
treatmentrel
gross
chang
microscop
examin
reveal
treatmentrel
patholog
find
day
three
treat
dog
increas
hemosiderosi
extramedullari
hematopoiet
activ
spleen
two
treat
dog
also
hemosiderinlik
pigment
hepat
kupffer
cell
debilit
dog
sacrif
prematur
moder
acut
bronchopneumonia
characterist
bilater
distribut
chang
found
central
nervou
system
three
treat
anim
day
treatment
frequent
affect
therefor
obvious
suscept
area
cerebellar
roof
nuclei
pontin
nuclei
vestibular
nuclei
paralemnisc
raph
region
extens
lesion
occur
prematur
sacrif
dog
involv
also
region
later
genicul
bodi
substantia
nigra
nucleu
ruber
even
neuron
gray
matter
lumbar
spinal
cord
chang
affect
nerv
cell
bodi
occasion
degener
nerv
fiber
probabl
repres
secondari
degener
process
damag
neuron
affect
neuron
character
loss
basophil
stain
probabl
reflect
loss
dissolut
nissl
bodi
perikarya
eosinophil
hematoxylin
eosin
pale
cresyl
violet
stain
chromatolyt
neuron
show
occasion
nuclear
eccentr
featur
resembl
axon
reaction
fig
advanc
lesion
character
shrinkag
nuclei
fragment
cytoplasm
silver
stain
demonstr
clump
breakdown
perikary
neurofila
necrot
neuron
surround
scaveng
microglia
cell
form
characterist
microgli
nodul
posit
rcal
lectin
bind
reaction
fig
peripher
nerv
lesion
found
brain
prematur
sacrif
anim
show
addit
lesion
cortex
hippocampu
featur
ischem
neuron
chang
probabl
nonspecif
associ
debilit
condit
anim
clinic
investig
intramuscular
administr
anim
show
reduc
activ
observ
highdos
male
day
highdos
femal
day
one
middos
male
day
addit
highdos
group
anim
show
saliv
vomit
day
one
femal
middos
group
singl
episod
saliv
day
detail
neurolog
examin
reveal
find
mean
bodi
weight
reduc
dosedepend
treat
group
differ
control
statist
signific
highdos
group
food
consumpt
decreas
femal
highdos
group
quantit
evalu
ofth
ecg
record
day
indic
prolong
mean
qt
interv
adjust
heart
rate
male
femal
midand
highdos
group
male
lowdos
group
see
fig
fig
neuron
cerebellar
roof
pale
cytoplasm
contain
eosinophil
fragment
center
anim
fig
x
fig
neuron
cerebellar
roof
show
clump
neurofila
remnant
silver
stain
anim
fig
bodian
silver
luxol
blue
x
fig
neuron
cerebellar
roof
show
nuclear
shrinkag
deep
eosinophilia
cytoplasm
surround
microglia
cell
anim
fig
x
heart
rate
pwave
pqinterv
qrscomplex
affect
follow
oral
administr
highdos
male
femal
vomit
hour
almost
administr
detail
neurolog
examin
conduct
day
reveal
treatmentrel
find
male
femal
anim
highdos
group
femal
middos
group
decreas
mean
bodi
weight
food
consumpt
significantli
decreas
femal
highdos
group
quantit
examin
ecg
record
day
indic
prolong
mean
qt
interv
male
femal
highdos
group
fig
effect
ecg
paramet
pharmacokinet
intramuscular
administr
determin
plasma
profil
indic
peak
level
around
hour
postdos
slow
elimin
tendenc
accumul
repeat
administra
artemeth
mglkg
p
artemettl
rngkg
p
izz
attemeth
mglkg
p
fig
qtinterv
adjust
heart
rate
beat
per
minut
group
mean
sd
given
male
femal
dog
receiv
either
oral
intramuscular
rout
tion
fig
two
hour
administr
low
level
found
cerebrospin
fluid
ora
concentr
level
quantif
tabl
oral
administr
rapidli
extens
metabol
dog
result
similar
consider
lower
plasma
profil
observ
im
administr
contrast
high
plasma
concentr
major
metabolit
dihydroartemisinin
ora
observ
day
show
peak
level
around
hour
postdos
day
peak
plasma
level
reach
day
exp
toxic
plasma
ora
concentr
almost
nil
throughout
entir
sampl
period
fig
indic
dog
repeat
oral
administr
may
induc
liver
enzym
result
fast
inactiv
ora
cerebrospin
fluid
neither
ora
found
tabl
patholog
examin
brain
dog
treat
oral
reveal
treatmentrel
chang
wherea
brain
dog
treat
intramuscularli
neuropath
lesion
incid
grade
reflect
doseeffect
relationship
lowdos
im
group
tabl
cumul
grade
find
affect
brain
area
beagl
dog
intramuscularli
treat
experi
base
individu
grade
brain
area
affect
cerebellar
roof
nuclei
pontin
nuclei
raph
paralemnisc
nuclei
vestibular
nuclei
cumul
grade
calcul
differ
lesion
type
maximum
possibl
score
max
grade
x
brain
area
x
anim
data
oral
administr
find
grade
absent
minim
slight
moder
mark
sever
blq
level
quantif
ngml
nd
detect
ngml
anim
show
slight
chang
wherea
middos
highdos
im
group
anim
affect
lesion
promin
tabl
surviv
anim
without
sever
sign
accord
find
genoves
et
al
observ
normal
behavior
perform
ae
treat
rat
measur
oper
condit
task
despit
substanti
neuron
damag
similarli
brewer
et
al
describ
dog
treat
ae
neurolog
chang
appear
shortli
death
sever
factor
may
contribut
appar
normal
function
despit
presenc
neuron
damag
neuron
reserv
capac
andor
capabl
nervou
system
compens
lost
neuron
area
affect
involv
mainli
auxilliari
function
absenc
earli
clinic
sign
could
act
warn
signal
neurotox
induc
intramuscular
evalu
great
caution
neurotox
chang
restrict
central
nervou
system
affect
primarili
nerv
cell
bodi
lesion
classifi
term
cellular
target
neuronopathi
earli
chang
character
dissolut
nissl
bodi
occasion
nuclear
eccentr
resembl
axon
reaction
known
occur
respons
damag
ofaxon
howev
wherea
axon
reaction
rough
endoplasm
reticulum
rearrang
neuron
peripheri
order
produc
cytoskeleton
need
reconstitut
damag
axon
krink
et
al
krink
fitzgerald
rearrang
occur
toxic
quit
possibl
initi
partial
neuron
damag
toxic
trigger
signal
involv
axon
reaction
transduct
signal
result
similar
remodel
neuron
soma
featur
neuron
chang
resembl
patholog
known
occur
spontan
motor
neuron
diseas
amyotrop
later
sclerosi
al
result
experi
demonstr
spectrum
toxic
chang
evok
excess
exposur
day
simultan
absenc
chang
shorter
exposur
period
day
exposur
level
mgkg
im
find
specif
associ
effect
decreas
motil
recumb
convuls
trend
toward
prolong
qt
interv
ecg
hypochrom
microcyt
anemia
correl
increas
hemosiderosi
spleen
liver
hematopoiet
activ
spleen
neuropath
chang
central
nervou
system
individu
anim
show
short
dramat
clinic
deterior
end
convuls
death
neuropatholog
chang
found
anim
well
propos
playa
role
etiolog
al
specif
malfunct
superoxid
dismutas
result
surplu
hydrogen
peroxid
hydroxyl
radic
peroxynitrit
damag
neuron
ceballospicot
sinc
oxid
mechan
involv
antiparasit
effect
conceiv
toxic
effect
could
employ
similar
mechan
act
neuron
excess
exposur
reason
select
distribut
lesion
brain
affect
lower
brain
stem
preserv
upper
brain
stem
cortex
unclear
may
reflect
select
vulner
affect
neuron
uneven
distribut
brain
explan
mechan
involv
neuron
damag
due
oxid
stress
usual
consid
trigger
apoptosi
studi
howev
nuclear
shrinkag
occur
rather
karyorrhexi
known
result
form
apoptosi
neuropathi
earli
microscop
chang
appear
affect
cytoplasm
apoptosi
seem
play
signific
role
therefor
mitig
overdos
scaveng
free
radic
could
relev
antidot
rather
agent
inhibit
apoptosi
quantit
evalu
ecg
experi
ii
indic
slight
prolong
mean
qt
interv
highdos
anim
dose
oral
rout
im
administr
midand
highdos
group
male
lowdos
group
contrast
earlier
report
brewer
et
al
invers
twave
observ
prolong
qt
interv
absenc
effect
qrsinterv
indic
stinterv
prolong
select
reflect
slow
ventricular
repolar
similar
effect
known
pharmaceut
quinidin
procain
two
compound
prolong
qt
interv
associ
danger
provok
syncop
sudden
death
increas
consid
threshold
concern
compar
pretest
valu
qt
interv
prolong
femal
mgkg
im
mgkg
im
oral
administr
prolong
anim
use
prolong
criterion
advers
increas
qt
interv
observ
im
administr
mgkg
artemeth
consid
toxicolog
relev
although
avail
data
allow
elucid
mechan
underli
ecg
chang
interest
note
prolong
qt
interv
occur
intramuscular
oral
administr
therefor
appear
unrel
neurotox
observ
im
administr
pharmacokinet
evalu
show
oral
treat
dog
contrast
intramuscular
treatment
rapidli
metabol
pharmacolog
activ
dha
result
low
plasma
level
parent
compound
high
plasma
level
metabolit
indic
low
plasma
level
dha
administr
repeat
administr
acceler
metabol
inactiv
unlik
dog
human
pharmacokinet
profil
dha
similar
administ
oral
im
rout
singl
oral
dose
mg
mgkg
bw
result
maximum
plasma
concentr
slightli
lower
higher
dha
level
im
administr
dose
karbwang
et
al
tejaisavadharm
et
al
repeat
oral
dose
human
lead
similar
rapid
metabol
inactiv
dog
na
bangchang
et
al
dog
intramuscular
administr
result
plasma
profil
dha
compar
observ
human
either
rout
administr
taken
togeth
result
experi
dog
indic
oral
administr
produc
neuropathi
high
exposur
level
repeat
intramuscular
treatment
mgkg
induc
neurotox
day
margin
effect
occur
anim
dose
day
base
differ
pharmacokinet
human
dog
could
question
result
obtain
oral
administr
dog
directli
extrapol
human
dose
oral
comparison
base
pharmacokinet
profil
show
healthi
anim
patient
dose
oral
initi
mgkg
plu
mgkg
follow
daili
mgkg
day
plasma
concentr
similar
observ
studi
dog
treat
mgkg
im
na
bangchang
et
ai
dog
dose
toler
day
effect
day
repres
level
neurotox
howev
human
neurotox
neither
observ
clinic
trial
kamchonwongpaisan
et
al
report
publish
literatur
gener
